Sutro Biopharma (STRO) Invested Capital (2016 - 2025)
Sutro Biopharma (STRO) has disclosed Invested Capital for 10 consecutive years, with -$132.5 million as the latest value for Q4 2025.
- Quarterly Invested Capital fell 396.97% to -$132.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$132.5 million through Dec 2025, down 396.97% year-over-year, with the annual reading at -$132.5 million for FY2025, 396.97% down from the prior year.
- Invested Capital hit -$132.5 million in Q4 2025 for Sutro Biopharma, down from -$87.3 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $310.6 million in Q2 2021 to a low of -$132.5 million in Q4 2025.
- Historically, Invested Capital has averaged $143.1 million across 5 years, with a median of $159.3 million in 2023.
- Biggest five-year swings in Invested Capital: surged 274.41% in 2021 and later plummeted 396.97% in 2025.
- Year by year, Invested Capital stood at $261.9 million in 2021, then dropped by 12.37% to $229.5 million in 2022, then tumbled by 33.04% to $153.7 million in 2023, then tumbled by 70.98% to $44.6 million in 2024, then crashed by 396.97% to -$132.5 million in 2025.
- Business Quant data shows Invested Capital for STRO at -$132.5 million in Q4 2025, -$87.3 million in Q3 2025, and -$32.1 million in Q2 2025.